Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1055


Advances in Coronary Angioplasty: Drug Eluting Stents


Description: The development of drug-eluting stents has emerged since the use of stenting became particularly prevalent, especially in the US. Stents are currently used in approximately 70%-90% of cardiovascular interventional procedures and have been shown to reduce the need for repeat percutaneous transluminal coronary angioplasty (Ptca) due to restenosis. There are, however, issues of in-stent thrombosis and in-stent restenosis that need to be addressed when analyzing the results of clinical trial data. Over the next few years, additional long-term studies will aim to provide details of the long-term outcome for drug-eluting stents. In light of recent advances in this field of research, this brief sets out to: *describe the stenting procedure and outline the overall use of stents in coronary interventional procedures *outline recent advances in procedures, such as brachytherapy and sonotherapy, and establish the main advantages and disadvantages of each type of intervention *analyze clinical trial data and company strategies for key drug-eluting stent programs, including in-depth review of sirolimus-eluting, paclitaxel-eluting and actinomycin D-eluting stent trials *compare drug-eluting stent developments against established interventions in order to determine the potential success and patient population for drug-eluting stents *provide a forecasted market size for the drug-eluting stent market to 2005, along with an identification of the key factors influencing the market during this period * analyze the potential impact of drug-eluting stents on pharmaceutical companies, in terms of the affect on the use of anti-thrombotic and anti restenotic agents.


Contents:
Datamonitor Healthcare


CONTACT DETAILS



TABLE OF CONTENTS


EXECUTIVE SUMMARY






Introduction


The history of angioplasty


Current use of stents in interventional therapy


Definition of stenting














In-stent restenosis


Increased intervention costs


Epidemiology overview


Percutaneous transluminal coronary angioplasty (PTCA)


Recent advances in stent therapy


Brachytherapy


Sonotherapy


Coated stents


Radioactive stents


Pipeline for drug-eluting stents


Sirolimus-eluting stent


RAVEL: zero restenosis


Cypher: Is it really too good to be true?


Will drug-eluting stents prove too costly?


Potential strategic alliances for Cordis


Market implications of drug-eluting stents


Paclitaxel-eluting stents


SCORE trial terminated


Increasing presence in the medical device market


Initial results from the paclitaxel-eluting stent trial


Strategic alliances to maximize potential revenue


Actinomycin D-eluting stent


Comparative analysis


Competition between drug-eluting stents


Market forecasts for drug-eluting stents


Potential impact on antithrombotic drug therapy?


Appendix


Bibliography








Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1055

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 05/01/2009 23:57:22
Fax Order Form

To place an order via fax simply print this form, fill in the information below and fax the completed form to the number at the bottom of this page. If you have any questions please email help@researchandmarkets.com


Order information

Please verify that the product information is correct and select the format you require.

Product Name:
Advances in Coronary Angioplasty: Drug Eluting Stents

Web Address:
http://www.researchandmarkets.com/reports/1055

Office Code:
OCIILHRLVSY

Report formats

Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €1,669.00 + EUR€ 50.00 Shipping/Handling *
Electronic €1,605.00
Electronic - Site License €1,605.00

* Shipping/Handling is only charged once per order.


Contact information

Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World

Research and Markets Page 2 of 2
Printed 05/01/2009 23:57:22


Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder Name:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.


If you have a Marketing Code please enter it below:

Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp



Please fax this form to:
(646) 607-1907 or (646) 964-6609 - From USA
+353 1 481 1716 or +353 1 653 1571 - From Rest of World